Home » Topics » Regulatory » Patents

Patents
RSS

Arena Pharmaceuticals patents new molecules for type 2 diabetes and obesity

Nov. 7, 2011

New GPR119 receptor agonists claimed

Nov. 7, 2011

Verseon presents novel thrombin inhibitors

Nov. 7, 2011

Merck & Co. discloses new fatty-acid amide hydrolase 1 inhibitors

Nov. 7, 2011

Novel radioprotective agents divulged by Peter MacCallum Cancer Centre

Nov. 7, 2011

Researchers at Lilly describe novel cannabinoid CB2 receptor agonists

Nov. 4, 2011

Novel casein kinase II inhibitors reported by BMS

Nov. 4, 2011

Korean company patents new glucagon GLP-1 receptor agonists

Nov. 4, 2011

Tetraphase Pharmaceuticals synthesizes new antibacterial agents

Nov. 4, 2011

Tibotec presents novel HIV integrase inhibitors

Nov. 4, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...